Renée Komorowski

Enhancement of therapeutic protein in vivo activities through glycoengineering

Steve Elliott, Tony Lorenzini, Sheilah Asher et al. · Nature Biotechnology · 2003 · 509 citations

Medicine, Glycobiology, Bioconjugation +5

Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys

Yumei Xiong, Kenneth W. Walker, Xiaoshan Min et al. · Science Translational Medicine · 2017 · 226 citations

Immunology, Food Intake, Long-acting Mic-1/gdf15 Molecules +17

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models

Elizabeth A. Killion, Jinghong Wang, Junming Yie et al. · Science Translational Medicine · 2018 · 217 citations · Full text

Glp-1r Agonists, Anti-obesity Effects, Immunology +20

Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex

Ian N. Foltz, Sylvia Hu, Chadwick King et al. · Science Translational Medicine · 2012 · 211 citations

Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue

Murielle M. Véniant, Glenn Sivits, Joan Helmering et al. · Cell Metabolism · 2015 · 194 citations

Metabolic Syndrome, Metabolic Disorder, Medicine +10